Beam Therapeutics Inc. (BEAM)

Healthcare · Biotechnology · NASDAQ

Beam Therapeutics Inc. (BEAM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.68B and a free-cash-flow yield of -14.0%. Over the most recent reported fiscal year, revenue grew 120.0%.

Market cap	$2.68B
Trailing P/E	—
FCF yield	-14.0%
Revenue growth (YoY)	+120.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live BEAM data on Nama Insights →